Your browser doesn't support javascript.
loading
Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives.
Roszak, Sara E; Ferreri, Stefanie P.
Affiliation
  • Roszak SE; Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina.
  • Ferreri SP; UNC Eshelman School of Pharmacy, Division of Practice Advancement and Clinical Education, 301 Pharmacy Lane, CB#7355, Chapel Hill, NC 27599-7355. Email: sararoszak@gmail.com.
Prev Chronic Dis ; 17: E90, 2020 08 20.
Article de En | MEDLINE | ID: mdl-32816661
ABSTRACT

INTRODUCTION:

Even though evidence-based diabetes prevention interventions exist, more than 1 in 3 Americans have prediabetes; the use of pharmacies has been explored as a way to reach and care for this population. The objective of this study was to analyze factors that influence adoption of type 2 diabetes prevention programs by community pharmacies.

METHODS:

We conducted 21 semistructured interviews in 2018 with decision makers from 11 independent pharmacies in 6 US states and the District of Columbia and from 10 chain pharmacies operating in 1 state, multiple states, and nationwide. We identified participants by using purposive sampling. We used qualitative methods to analyze data and conducted interviews until we reached saturation.

RESULTS:

Multiple themes emerged 1) initiation of services is more likely if initial financial support is received; 2) patient demand for services, actual or perceived, is paramount; 3) diabetes prevention services often fit within the existing operations of a pharmacy and allow maximum use of resources; 4) customer loyalty is a clearly articulated advantage against competition; and 5) engagement in diabetes prevention affirms an expanded role and the value of pharmacies to serve communities.

CONCLUSION:

Pharmacies are well situated to deliver diabetes prevention programs to communities. Although considerable opportunity exists for pharmacies to address diabetes prevention, more could be done to reduce barriers to their use.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pharmacies / Services de médecine préventive / Diabète de type 2 Type d'étude: Prognostic_studies / Qualitative_research Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Prev Chronic Dis Sujet du journal: SAUDE PUBLICA Année: 2020 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pharmacies / Services de médecine préventive / Diabète de type 2 Type d'étude: Prognostic_studies / Qualitative_research Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Prev Chronic Dis Sujet du journal: SAUDE PUBLICA Année: 2020 Type de document: Article